Lorne Yudcovitch
Optometrist · Forest Grove, ORNPI 1487645586
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (44.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 52.1% of the total. Reporting peaked in 2023 at $3,390 and has fallen 91.3% since, to $295 in 2025. Among optometrist clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $170.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$3K
- AbbVie$847
- Johnson & Johnson Vision Care, Inc.$326
- Coopervision Inc.$280
- Genentech USA, Inc.$257
- Bausch & Lomb Americas Inc.$210
- plus $1K from 13 others
What the payments were for
- Consulting fees$80013%
- Travel & lodging$2,80344%
- Food & beverage$2,70443%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 6 | $3,285 |
| AbbVie | 3 | $847 |
| Johnson & Johnson Vision Care, Inc. | 4 | $326 |
| Coopervision Inc. | 4 | $280 |
| Genentech USA, Inc. | 2 | $257 |
| Bausch & Lomb Americas Inc. | 2 | $210 |
| Ocular Therapeutix, Inc. | 1 | $151 |
| Sun Pharmaceutical Industries Inc. | 2 | $142 |
| Amgen(2 entities) | 2 | $138 |
| Sanofi | 2 | $134 |
| Spark Therapeutics, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $111 |
| Aerie Pharmaceuticals, Inc. | 1 | $97 |
| Biotissue Holdings Inc. | 1 | $63 |
| Sight Sciences, Inc. | 1 | $43 |
| Dompe US, Inc. | 1 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Tarsus Pharmaceuticals, Inc. | 1 | $22 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CIRRUS HD-OCT$3,176
- CLARUS$3,176
- FORUM$3,176
- Humphrey Field Analyzer (HFA3)$3,176
- IOLMaster 700$3,176
- DURYSTA$800
- LUMIGAN$800
- XEN GLAUCOMA TREATMENT SYSTEM$800
- Lucentis$257
- Acuvue$225
- LUXTURNA$125
- VYZULTA$125
- CEQUA$125
- FABRAZYME$119
- TEPEZZA$118
- EYLEA$111
How this compares
$6,307 in reported general payments places this provider in the 95th percentile of 684 optometrist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 87 | $894 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $442 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Forest Grove
- Cristina SchniderForest Grove$204K
- Yue LiuForest Grove$139K
- Christi ClossonForest Grove$80K
- Frank ZhengForest Grove$78K
- Chi NguyenForest Grove$40K
- Matthew LampaForest Grove$24K
- Sheila MorrisonForest Grove$7K
- Jamy BorbidgeForest Grove$7K
- Gwen BuiForest Grove$4K
- Mari FujimotoForest Grove$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.